✦ LIBER ✦

A phase III trial of docetaxel–estramustine in high-risk localised prostate cancer: A planned analysis of response, toxicity and quality of life in the GETUG 12 trial

✍ Scribed by Karim Fizazi; Francois Lesaunier; Remy Delva; Gwenaëlle Gravis; Frederic Rolland; Frank Priou; Jean-Marc Ferrero; Nadine Houedé; Loïc Mourey; Christine Theodore; Ivan Krakowski; Jean-François Berdah; Marjorie Baciuchka; Brigitte Laguerre; Aude Fléchon; Alain Ravaud; Isabelle Cojean-Zelek; Stéphane Oudard; Jean-Luc Labourey; Jean-Léon Lagrange; Paule Chinet-Charrot; Claude Linassier; Gaël Deplanque; Philippe Beuzeboc; Jean Geneve; Jean-Louis Davin; Elodie Tournay; Stephane Culine

Book ID: 116430908
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 521 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/j.ejca.2011.10.015

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute toxicity of curative radiotherapy

Acute toxicity of curative radiotherapy for intermediate- and high-risk localised prostate cancer in the EORTC trial 22991

✍ O. Matzinger; F. Duclos; A. van den Bergh; C. Carrie; S. Villà; P. Kitsios; P. P 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 531 KB

A randomized hypofractionation dose esca

A randomized hypofractionation dose escalation trial for high risk prostate cancer patients: interim analysis of acute toxicity and quality of life in 124 patients

✍ Norkus, Darius; Karklelyte, Agata; Engels, Benedikt; Versmessen, Harijati; Grisk 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 280 KB

Phase 2 study of neoadjuvant docetaxel p

Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer : A Prostate Cancer Clinical Trials Consortium trial

✍ Robert W. Ross; Matthew D. Galsky; Phil Febbo; Marc Barry; Jerome P. Richie; Wan 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

The SUCCESS-Trial -toxicity analysis of

The SUCCESS-Trial -toxicity analysis of a phase III study evaluating the role of Docetaxel and Gemcitabine in the adjuvant therapy of breast cancer patients

✍ W. Janni; E. Genss; B. Rack; H. Sommer; M. Rezai; A. Schneider; W. Lichtenegger; 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 73 KB

Docetaxel (Taxotere) shows survival and

Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials

✍ Frances A Shepherd; Frank V Fossella; Thomas Lynch; Jean-Pierre Armand; James R 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 602 KB

Docetaxel (Taxotere) shows survival and

Docetaxel (Taxotere) shows survival and quality-of-life benefits in the second-line treatment of non-small cell lung cancer: A review of two phase III trials

✍ Frances A. Shepherd; Frank V. Fossella; Thomas Lynch; Jean-Pierre Armand; James 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 602 KB